-
Mashup Score: 5Prostate Cancer Screening in High-Risk Groups: Challenges to Screening | GU Oncology Now - 1 day(s) ago
Dr. Nyame shared highlights from his presentation on PC screening in high-risk groups as part of an AUA plenary session.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 5KEYNOTE-057: Pembrolizumab Monotherapy Shows Promise for Patients With High-Risk NMIBC | GU Oncology Now - 2 day(s) ago
The primary end point of the analysis of cohort B was 12-month disease-free survival.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6
The panel engages in a discussion related to risk stratification in UTUC, including identification of high-risk patients.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7
Dr. Spiess highlights prevalence of TERT expression and an increase in TROP-2 mRNA expression levels in PSCC patients.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 9The Uromigos Episode 315: ACCC 2024 - Bone Health, Hot Flashes and Gynecomastia in Prostate Cancer | GU Oncology Now - 4 day(s) ago
Chris Sweeney is joined by fellow experts to discuss supportive care for side effects of mHSPC such as bone weakness, hot flashes, and gynecomastia.
Source: guoncologynow.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4
Drs. Murray and Lotan highlight a recent multicenter study featuring longitudinal follow-up of UGN-101 for UTUC.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Apalutamide Plus ADT May Benefit Patients With High-Risk Localized Prostate Cancer | GU Oncology Now - 5 day(s) ago
The trial evaluated the data of treatment-naΓ―ve patients who underwent RP and received apalutamide as well as ADT.
Source: guoncologynow.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
Dr. Soon-Shiong provides an overview of the groundbreaking data related to nogapendekin alfa inbakicept for NMIBC.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0Preoperative Risk Calculator for Evaluating Nephron-Sparing Completion in Kidney Cancer | GU Oncology Now - 5 day(s) ago
Researchers analyzed the connection between the outcomes and specific predictors of interest.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Impact of Cytoreductive Nephrectomy on Survival Benefits for Patients With Metastatic nccRCC | GU Oncology Now - 6 day(s) ago
In patients with RCC, around 20% demonstrate non-clear cell histology, including various histology types.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
π #ICYMI: At #AUA24, we talked with @yawnyame of @fredhutch about the βhigh-riskβ population in #ProstateCancer as well as how different natural history affects screening results and implications for early detection. πΊ Watch Now: https://t.co/GO5M47kmEq https://t.co/GXHtvkxwwd